Add BrightSurf on Google Email

Self-reported “night owls” more likely to have unhealthy lifestyle behaviors, significantly increased diabetes risk

A large study found that people with an evening chronotype were more likely to engage in unhealthy lifestyle behaviors such as smoking, poor sleep, and physical inactivity. These individuals had a 72% higher risk of developing diabetes compared to those with a morning chronotype.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateSep 11, 2023

Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

A new study published in Clinical Gastroenterology and Hepatology found an association between breastfeeding as an infant and an increased risk of colorectal cancer in adulthood. Researchers analyzed data from over 158,000 women and discovered that breastfed individuals were 23% more likely to develop colorectal cancer later in life.

SourceDana-Farber Cancer Institute·JournalClinical Gastroenterology and Hepatology·DateSep 6, 2023

Statins linked to lower risk of colorectal cancer in patients with ulcerative colitis

Researchers at Karolinska Institutet found that statin treatment was associated with a lower risk of developing and dying from colorectal cancer in patients with ulcerative colitis. After a follow-up period of 5.6 years, the study showed that 70 statin users had been diagnosed with colorectal cancer compared to 90 non-statin users.

SourceKarolinska Institutet·JournalEClinicalMedicine·TypeObservational study·DateSep 1, 2023

Mayo Clinic researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer

Mayo Clinic researchers found that cells expressing PD-1 and PD-L1 within a certain distance of each other can predict the success of immunotherapy in patients with colorectal cancer. This spatial analysis may help select patients most likely to benefit from treatment, improving outcomes and minimizing unnecessary treatments.

SourceMayo Clinic·JournalClinical Cancer Research·DateAug 31, 2023

AI predictions for colorectal cancer: One step closer to efficient precision oncology

Researchers from Helmholtz Munich and TU Dresden develop AI-powered biomarker detection that outperforms previous approaches. The algorithm achieves high sensitivity on resection tissue samples and shows promise as a pre-screening tool for biopsy tissue.

Estimated lifetime gained with cancer screening tests

A systematic review and meta-analysis of 18 clinical trials involving 2.1 million individuals found no significant lifetime gain from common cancer screening tests. However, colorectal cancer screening with sigmoidoscopy may have a potential benefit, according to the study.

SourceJAMA Network·JournalJAMA Internal Medicine·DateAug 28, 2023

BU commentary: Vitamin D supplementation was found to improve more than 1.5 fold survival of cancers of the digestive tract including colorectal cancer in patients with a cancer fighting immune system

A new commentary suggests that vitamin D supplementation can improve survival outcomes for patients with digestive tract cancers, particularly those with a high-risk genetic makeup. The study found that patients with antibodies to control the production of mutated p53 protein saw improved survival rates when taking daily vitamin D3 sup...

SourceBoston University School of Medicine·JournalJAMA Network Open·TypeCommentary/editorial·DateAug 22, 2023

Statistician earns $1.7M to study long-term effects of neighborhood exposures and racial segregation on cancer risk

A statistician at Virginia Commonwealth University has been awarded a $1.7 million grant to investigate the long-term effects of neighborhood exposures and racial segregation on cancer risk. The researcher aims to better understand how geographic and socioeconomic factors contribute to disparities in cancer incidence and mortality.

CORRECTION: Outdoor air pollution may increase non-lung cancer risk in older adults

A Harvard T.H. Chan School of Public Health study found that chronic exposure to fine particulate air pollutants (PM2.5) and nitrogen dioxide (NO2) increases the risk of colorectal and prostate cancers in older adults. NO2 exposure was also associated with an increased risk of breast cancer, while PM2.5 exposure had mixed results.

SourceHarvard T.H. Chan School of Public Health·JournalEnvironmental Epidemiology·TypeObservational study·DateAug 11, 2023

ACP issues updated guidance for colorectal cancer screening of asymptomatic adults

The American College of Physicians recommends starting colorectal cancer screening at age 50 for asymptomatic adults with average risk. The guideline aims to balance benefits and harms of screening in this population. Screening in younger adults may not offer significant net benefit due to lower incidence rates.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJul 31, 2023

Transcription factors contribute to subtypes of colorectal cancers

Researchers found that expression of transcription factors contributes to different subtypes of colorectal cancers. The degree of DNA methylation varies across tissue types, with some cancers having high and others low frequency of methylation gains. Studying transcription factor expression may help determine overall survival in patien...

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateJul 27, 2023

Missing a rare cause of hereditary cancer

Researchers identified methylation in normal tissues in some patients with mismatch repair deficiency, leading to undiagnosed Lynch syndrome. This study suggests revising current screening guidelines to include this poorly recognized cause of hereditary cancer.

SourceCedars-Sinai Medical Center·JournalJournal of the National Comprehensive Cancer Network·TypeNews article·DateJul 11, 2023

A new generic treatment for multiple types of cancer

Researchers have developed a new technique to generically treat several kinds of cancer, showing tumors grew almost three times less and survival rates reached 100% after just one injection. The method targets cancer cells with alpha radiation, sparing healthy tissue.

SourceRIKEN·JournalChemical Science·DateJun 27, 2023

Changing the therapeutic landscape for patients with refractory metastatic colorectal cancer: FRESCO-2 supports fruquintinib as a global treatment option

The FRESCO-2 phase III study demonstrated statistically significant improvements in overall survival and progression-free survival in patients with refractory metastatic colorectal cancer treated with fruquintinib. Fruquintinib showed a favorable safety profile, with patients staying on treatment almost twice as long as those on placebo.

SourceVall d'Hebron Institute of Oncology·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateJun 26, 2023

A new tool for diagnosing cancer

Researchers developed a new tool called Orion that integrates histologic and molecular information to improve cancer diagnosis and treatment. The tool uses a digital imaging platform to analyze tumor samples, identifying biomarkers that predict patient outcomes.

SourceHarvard Medical School·JournalNature Cancer·DateJun 22, 2023

Mutant KRAS regulates Y chromosome gene in colorectal cancer, driving metastasis and inhibiting anti-tumor immunity

A preclinical study has uncovered the role of Y chromosome gene KDM5D in regulating anti-tumor immune responses and promoting metastasis in male patients with KRAS-mutated colorectal cancer. The study reveals that mutant KRAS drives upregulation of KDM5D, leading to reduced cell adhesion and immune recognition by the immune system.

Certain cancers will likely rise exponentially due to COVID-19 screening delays

A new study published in the Journal of the American College of Surgeons predicts a significant increase in cancer cases due to COVID-19 screening delays, with lung, breast, and colorectal cancers most affected. The study found that missed diagnoses during the pandemic may lead to delays in treatment and upstaging of disease.

SourceAmerican College of Surgeons·JournalJournal of the American College of Surgeons·DateMay 25, 2023

Journal of Pharmaceutical Analysis studies shine the light on advancements in pharmaceutical analytical techniques and overcoming chemoresistance

Researchers have developed new methods to analyze dry-coated drug particles using 3D Raman mapping, which can effectively slow down dissolution rates. Another study introduces a novel technique for detecting complex traditional Chinese medicines, preventing adulteration and counterfeiting.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateMay 24, 2023

Obesity as a risk factor for colorectal cancer underestimated so far

A recent study has shown that obesity is a significant risk factor for colorectal cancer, with overweight individuals having a one-third higher risk of developing the disease. The study also found that unintentional weight loss in the years leading up to diagnosis may be an early indicator of colorectal cancer.

Red flags indicate risk for early-onset colorectal cancer

Researchers have found four key red flags for early-onset colorectal cancer, including abdominal pain and rectal bleeding, which can indicate an increased risk in younger adults. Early detection through timely endoscopy and follow-up is crucial to improve survival rates.

SourceWashU Medicine·JournalJNCI Journal of the National Cancer Institute·TypeData/statistical analysis·DateMay 4, 2023

Six-fold increase in rural cancer screenings with remote outreach

A new study found that remote outreach involving interactive education and follow-up support via telephone increased breast, cervical, and colorectal cancer screening rates among rural women. The combination of a remotely delivered interactive DVD and patient navigation services resulted in a six-fold increase in screenings.

SourceOhio State University Wexner Medical Center·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateApr 28, 2023

Memorial Sloan Kettering Cancer Center experts to present noteworthy research at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Memorial Sloan Kettering Cancer Center experts to present significant advances in cancer research at the American Association for Cancer Research Annual Meeting. MSK faculty will also receive prestigious awards and lectureships, highlighting their contributions to precision medicine and tumor biology.

Study unravels pathophysiological role of Dectin-1 in promoting colorectal cancer

A study led by Tokyo University of Science researchers identified Dectin-1's role in promoting colorectal cancer by enhancing PGE2 production and suppressing IL-22BP expression. The study used mouse models and clinical samples to validate the findings, which have immediate clinical implications for CRC patients.

SourceTokyo University of Science·JournalNature Communications·TypeExperimental study·DateApr 10, 2023